Literature DB >> 16954244

Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis.

H Sokol1, P Lepage, P Seksik, J Doré, P Marteau.   

Abstract

Previous studies of the endogenous microbiota in patients with ulcerative colitis (UC) have not taken bacterial activity into account, yet bacteria with high transcriptional activity might have a more important pathophysiological role than inactive bacteria. We therefore analyzed the biodiversity of active bacteria in the fecal microbiota of UC patients, in comparison with that of healthy subjects. Feces were collected from nine patients with active UC and from nine healthy controls. Total DNA and RNA were extracted, and 16S ribosomal DNA and RNA were amplified by PCR and reverse transcription-PCR, respectively. Amplification products were compared by means of temporal temperature gradient gel electrophoresis (TTGE). Bands of interest were excised, sequenced, and identified by comparison with the GenBank database (NCBI). The dominant-species diversity based on RNA-derived TTGE profiles was significantly lower for UC patients than for healthy controls (P = 0.01). The mean similarity index between the "present" and "active" microbiota was 74% +/- 18% for UC patients. Comparison of the individual "active" microbiota identified a band that was present for eight UC patients and only two controls (89% versus 22%; P = 0.008). The band was sequenced for 6 patients and always corresponded to Escherichia coli. The biodiversity of active bacteria in the dominant fecal microbiota of patients with UC is lower than that of healthy subjects. E. coli is more represented in the active microbiota of UC patients. The possible pathophysiological role of this difference remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954244      PMCID: PMC1594675          DOI: 10.1128/JCM.02600-05

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  rrndb: the Ribosomal RNA Operon Copy Number Database.

Authors:  J A Klappenbach; P R Saxman; J R Cole; T M Schmidt
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.

Authors:  R A Welch; V Burland; G Plunkett; P Redford; P Roesch; D Rasko; E L Buckles; S-R Liou; A Boutin; J Hackett; D Stroud; G F Mayhew; D J Rose; S Zhou; D C Schwartz; N T Perna; H L T Mobley; M S Donnenberg; F R Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

3.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

4.  Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater.

Authors:  Tohru Shimizu; Kaori Ohtani; Hideki Hirakawa; Kenshiro Ohshima; Atsushi Yamashita; Tadayoshi Shiba; Naotake Ogasawara; Masahira Hattori; Satoru Kuhara; Hideo Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis.

Authors:  H Matsuda; Y Fujiyama; A Andoh; T Ushijima; T Kajinami; T Bamba
Journal:  J Gastroenterol Hepatol       Date:  2000-01       Impact factor: 4.029

7.  Enteropathogenicity and antimicrobial susceptibility of new Escherichia spp.

Authors:  A Chaudhury; G Nath; A Tikoo; S C Sanyal
Journal:  J Diarrhoeal Dis Res       Date:  1999-06

8.  Colonic bacteria express an ulcerative colitis pANCA-related protein epitope.

Authors:  O Cohavy; D Bruckner; L K Gordon; R Misra; B Wei; M E Eggena; S R Targan; J Braun
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis.

Authors:  M C Pitcher; E R Beatty; J H Cummings
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

10.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Authors:  P Seksik; L Rigottier-Gois; G Gramet; M Sutren; P Pochart; P Marteau; R Jian; J Doré
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  65 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

2.  The bacterial pathogenesis and treatment of pouchitis.

Authors:  S D McLaughlin; S K Clark; P P Tekkis; R J Nicholls; P J Ciclitira
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

3.  Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis.

Authors:  H Sokol; P Lepage; Ph Seksik; J Doré; Ph Marteau
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

4.  An efficient RNA extraction method for estimating gut microbial diversity by polymerase chain reaction.

Authors:  Seungha Kang; Stuart E Denman; Mark Morrison; Zhongtang Yu; Chris S McSweeney
Journal:  Curr Microbiol       Date:  2009-01-22       Impact factor: 2.188

5.  Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

Authors:  Harry Sokol; Nadia Vasquez; Nadia Hoyeau-Idrissi; Philippe Seksik; Laurent Beaugerie; Anne Lavergne-Slove; Philippe Pochart; Philippe Marteau
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

6.  Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice.

Authors:  Jingxiao Ye; Jimmy W Lee; Laura L Presley; Elizabeth Bent; Bo Wei; Jonathan Braun; Neal L Schiller; Daniel S Straus; James Borneman
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

Review 7.  The gut microbiota in IBD.

Authors:  Chaysavanh Manichanh; Natalia Borruel; Francesc Casellas; Francisco Guarner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

8.  Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).

Authors:  Harald Matthes; Thomas Krummenerl; Manfred Giensch; Corinna Wolff; Jürgen Schulze
Journal:  BMC Complement Altern Med       Date:  2010-04-15       Impact factor: 3.659

9.  Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions.

Authors:  Rodrigo Bibiloni; Eduardo J Schiffrin
Journal:  Int J Inflam       Date:  2010-09-29

10.  Host responses to intestinal microbial antigens in gluten-sensitive mice.

Authors:  Jane M Natividad; Xianxi Huang; Emma Slack; Jennifer Jury; Yolanda Sanz; Chella David; Emmanuel Denou; Pinchang Yang; Joseph Murray; Kathy D McCoy; Elena F Verdú
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.